Literature DB >> 15634330

The Rab5 effector Rabaptin-5 and its isoform Rabaptin-5delta differ in their ability to interact with the small GTPase Rab4.

Elena Korobko1, Sergey Kiselev, Sjur Olsnes, Harald Stenmark, Igor Korobko.   

Abstract

Rabaptin-5 is an effector for the small GTPase Rab5, a regulator of the early steps in endocytosis. In addition, Rabaptin-5 interacts with the small GTPase Rab4 that has been implicated in recycling from early endosomes to the cell surface. Recently we have identified a ubiquitous transcript encoding the Rabaptin-5 isoform, Rabaptin-5delta. To evaluate the interaction properties of Rabaptin-5delta with the small GTPases Rab4 and Rab5, we have applied protein interaction assays using the yeast two-hybrid system and a glutathione S-transferase pull-down assay. We found that unlike Rabaptin-5, that interacts with both GTPases in GTP-bound conformations, Rabaptin-5delta interacts only with GTP-bound Rab5, and does not interact with Rab4, presumably due to a disrupted Rab4 binding site. Immunofluorescence microscopy analysis carried out to address the localization of Rabaptin-5delta relative to GTP-bound Rab4 and Rab5 in BHK-21 cells supported these data. Our data suggests that while Rabaptin-5 was proposed to act as a molecular linker between Rab5 and Rab4, to coordinate endocytic and recycling traffic, Rabaptin-5delta is involved only in the Rab5-driven events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634330     DOI: 10.1111/j.1742-4658.2004.04387.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  2 in total

1.  A fresh look at the function of Rabaptin5 on endosomes.

Authors:  Simone Kälin; Dominik P Buser; Martin Spiess
Journal:  Small GTPases       Date:  2016

2.  Identification of Nedd4 E3 ubiquitin ligase as a binding partner and regulator of MAK-V protein kinase.

Authors:  Svetlana V Kalinichenko; Keiji Itoh; Elena V Korobko; Sergei Y Sokol; Vladimir L Buchman; Igor V Korobko
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.